Vascular Pathways, Inc. Signs New Agreement With Amerinet for AccuCath(R) Line of Catheters
BOCA RATON, FL--(Marketwired - February 05, 2015) - Vascular Pathways, Inc., a privately held medical device manufacturer with innovative wire guided technology for peripheral intravascular access, today announced a new agreement with Amerinet, a national healthcare solutions organization, for their range of AccuCath® Catheters. The agreement is effective February 1, 2015 through January 31, 2018.
Through this new agreement, Amerinet members will have access at exclusive member rates to Vascular Pathways, Inc.'s proprietary line of coiled-tip guidewire catheters designed to increase first attempt success, reduce complication rates, extend dwell times, increase patient satisfaction, and lower overall costs to the provider.
"At Vascular Pathways, we are committed to providing high-quality products that enhance patient outcomes and we are pleased to continue achieving that goal through our new partnership with Amerinet," said Bill Bold, President and CEO. "We look forward to the improvements and overall benefits to the health care industry that will come as a result of this collaboration."
As a leading national healthcare solutions organization, Amerinet collaborates with acute and non-acute care providers to create and deliver unique solutions through performance improvement resources, guidance and ongoing support. With better product standardization and utilization, new financial tools beyond contracting and alliances that help lower costs, raise revenue and champion quality, Amerinet enriches healthcare delivery for its members and the communities they serve. To learn more about how Amerinet can help you successfully navigate the future of healthcare reform, visit www.amerinet-gpo.com.
About Vascular Pathways, Inc.
Founded in 2005, by Amir Belson, M.D., Vascular Pathways is a medical device company commercializing the AccuCath® IV Catheter System Line, an FDA cleared, guidewire catheter system enabling rapid, safe, and successful IV insertion. Vascular Pathways, Inc. is privately held by CHL Medical Partners, Ascension Health Ventures, and MVM Life Sciences. For further information about Vascular Pathways or the AccuCath® IV catheter line, please visit http://www.vascularpathways.com or call 844-VASPATH.